U.S. drug regulators unmoved by Pfizer plan to seek Covid booster authorization

Dow Jones2021-07-09

MW U.S. drug regulators unmoved by Pfizer plan to seek Covid booster authorization

In an unusual exchange, the Food and Drug Administration and the Center for Disease Control on Thursday said there isn't scientific evidence that COVID-19 booster shots are required, hours after drug maker Pfizer $(PFE)$ said it would seek authorization for a Covid booster shot to help contain the Delta variant.

The outlook: The race between vaccines and the virus is still on. Meanwhile, as Daly noted, large parts of the world remain unvaccinated, a major headwind on global growth.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
8